Eptifibatide is a cyclic heptapeptide pharmaceutical raw material that functions as a platelet aggregation inhibitor. It is a synthetic compound with multiple amide and amine functional groups, characterized by a complex macrocyclic structure containing a disulfide bridge and aromatic rings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 188627-80-7
Triflusal
pharmaceutical raw material
Prasugrel
platelet aggregation inhibitor
(2S)-Hydroxy(phenyl)acetic acid (2R)-N-benzyl-1-(4-methoxyphenyl)propan-2-amine
pharmaceutical raw material
D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)carbonyl]amino]-
pharmaceutical raw material
4-(2-(tert-butylamino)-1-hydroxyethyl)-2-methylphenol
pharmaceutical raw material
4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(methoxymethyl)phenol
pharmaceutical raw material
Eptifibatide
pharmaceutical raw material
2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid
CZKPOZZJODAYPZ-LROMGURASA-N
C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N